Skip to main content
. Author manuscript; available in PMC: 2018 Jul 2.
Published in final edited form as: Exp Mol Pathol. 2018 Jan 4;104(1):50–58. doi: 10.1016/j.yexmp.2018.01.001

Table 1.

Demographic and clinical characteristics of the study population

All Cases
ALT ≥40 IU/L
Controls
ALT <40 IU/L
P-value
N (%) 632 178 (28.2) 454 (71.8)
Age (years) 48.7 ± 12.8 46.8 ± 11.2 49.5 ± 13.3 0.009
Sex (male %) 25.95 42.70 19.38 1.8×10−9
Education Level
≤ 6 years 17.09 11.80 19.16 0.041
≤ 12 years 39.08 42.70 37.67
> 12 years 42.41 42.70 42.29
Hypertension
No 74.37 71.35 75.55 0.276
Yes 25.63 28.65 24.45
BMI (kg/m2) 27.1 ± 4.7 29.4 ± 4.5 26.2 ± 4.5 1.5×10−14
Glucose (mg/dl) 99.1 ± 33.5 105.2 ± 33.5 96.8 ± 33.2 0.004
Total cholesterol (mg/dl) 200.3 ± 39.7 199.0 ± 36.2 200.8 ± 41.0 0.599
Triglycerides (mg/ml) 169.2 ± 119.1 200.0 ± 102.3 157.1 ± 123.1 8.5×10−10
HDL-C (mg/ml) 38.7 ± 11.9 36.4 ± 9.6 39.5 ± 12.6 8.8×10−4
LDL-C (mg/dl) 124.6 ± 36.9 123.6 ± 35.1 125.0 ± 37.5 0.666
ALT (IU/L) 31.9 ± 26.5 64.8 ± 29.5 19.0 ± 7.0 2.2×10−49
AST (IU/L) 26.0 ± 16.1 44.6 ± 19.4 18.6 ± 5.1 9.9×10−42

Results are presented as means ± standard deviations or n (%).

P values were obtained by comparing cases to controls.

Differences between proportions were performed using chi-square tests of homogeneity and differences between means were performed using t-test. Triglycerides were log-transformed before the analysis.

Abbreviations: BMI, body mass index; HDL-C, High Density Lipoprotein Cholesterol; HDL-C, Low Density Lipoprotein Cholesterol; ALT, alanine transaminase; AST, aspartate transaminase.